Pitching sessions

Future Stars - SBA Biotech Pitch Session

Pitching session summary

The Future Stars – SBA Biotech Pitch Session showcases a curated group of high-quality Swiss biotech companies developing innovative solutions across therapeutics, diagnostics, and enabling technologies. Each company will present its vision, science, and value proposition in a concise pitch, followed by a live Q&A. The session offers investors, partners, and industry leaders early insight into the next wave of Swiss biotech innovation.

Date, time and room information

Monday, May 4, 16:30 - 18:15, room Shanghai 3+4

Moderation

Name	Position	Institution
Urech David	Vice President	Swiss Biotech Association
Ernst Bettina	Vice President	Swiss Biotech Association

Pitching companies

Company name	Pitcher	Title of presentation	Link to company website
Allegria Therapeutics AG	Patrick Sieber	Mastering Mast Cells.	https://allegriatx.com/
Aukera Therapeutics GmbH	Stefan Imseng		https://www.aukera-tx.com/
ClearideBio Therapeutics AG	Xiaona Jing		https://www.clearidebiotx.com/
Immitra Bio GmbH	Amir Taheri		https://immitrabio.com/
InkoCell	Mathieu Girardin	Transforming Immune Cells into Next-Gen Therapies	https://www.inkocell.com/
InkVivo Technologies AG	Elia Guzzi	Data‑Driven Biomaterials for Smarter Drug Formulation	https://inkvivo.tech/
INTERAX	Andrew Roberts		https://interaxbiotech.com/
MetaLead	Michal Shoshan	MetaLead’s journey from chelation therapy to radioligand therapy	https://metalead.ch/
MyoPax	Verena Schoewel	MyoPax: Vanguard Cell and Gene Therapies for Muscle Repair	https://myopax.com/
Nerai Bioscience	Vincent Forster	One editor, many cures: scalable genome editing for rare diseases	https://nerai.bio/
Phialogics	Natalia Novac	Phialogics-native biologics platform restoring immune balance	https://www.phialogics.net/
Seito Biologics AG	Ufuk Karakus		https://www.seitobio.ch/

Jury members

Name	Position	Institution
Luca Bollinger
Markus Goebel
Patrick Burgermeister

Swiss Biotech Association